Angelika Mielcarek

ORCID: 0000-0002-4060-9975
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metal-Organic Frameworks: Synthesis and Applications
  • Nanoparticle-Based Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Graphene and Nanomaterials Applications
  • Dendrimers and Hyperbranched Polymers
  • Advanced biosensing and bioanalysis techniques
  • Nanoparticles: synthesis and applications
  • Covalent Organic Framework Applications
  • Telomeres, Telomerase, and Senescence
  • Gallbladder and Bile Duct Disorders
  • Medical Imaging and Pathology Studies
  • RNA Interference and Gene Delivery
  • Advanced Drug Delivery Systems

Adam Mickiewicz University in Poznań
2021-2024

Centre National de la Recherche Scientifique
2017-2023

ESPCI Paris
2021-2023

École Normale Supérieure - PSL
2022-2023

Université Paris Sciences et Lettres
2018-2022

Institut des Matériaux Poreux de Paris
2021

École Normale Supérieure
2021

Institut de Chimie et des Matériaux Paris-Est
2021

Université Paris-Sud
2017-2018

Chimie ParisTech
2017-2018

Abstract Despite high morbidity and mortality associated with lung diseases, addressing drugs towards tissue remains a pending task. Particle filtration has been proposed for passive targeting drug delivery. However, toxicity issues derived from the long‐term presence of particles must be overcome. By exploiting some ignored properties nanosized metal–organic frameworks it is possible to achieve impressive antitumoral effects on experimental tumors, even without need engineer surface...

10.1002/ange.201707346 article EN Angewandte Chemie 2017-09-28

We report a novel superparamagnetic stimuli-responsive nano-object coupling MIL-100(Fe) and maghemite, which, once combined with two complementary drugs (MTX Dox), leads to multifunctional theranostic platform treat inflammatory diseases.

10.1039/d2tb02094g article EN Journal of Materials Chemistry B 2023-01-01

Abstract Radiolabeling and nuclear imaging techniques are used to investigate the biodistribution patterns of soft hard protein corona around poly (lactic‐co‐glycolic acid) nanoparticles (PLGA NPs) after administration healthy mice. Soft coronas 131 I‐labeled BSA or serum formed on PLGA NPs functionalized with either polyehtylenimine (PEI) bovine albumin (BSA). The exchangeability is assessed in vitro by gamma counting exposing non‐labeled BSA, serum, simulated body fluid. PEI form larger...

10.1002/smll.202309616 article EN Small 2024-04-02

In article number 1707365, Patrick Couvreur, Christian Serre, and co-workers evaluate the biomedical applications of metal–organic frameworks at preclinical stage, for pharmacological or toxicity evaluation. Current surface-engineering approaches, in vivo studies, their prospects are considered. The back cover image illustrates circulation drug-loaded MOF nanoparticles a blood vessel. particular, nanosized cages MIL-100(Fe) loaded with Ibuprofen drug represented. Cover project designed by...

10.1002/adma.201870281 article EN Advanced Materials 2018-09-01

Nanoparticles of metal-organic frameworks (MOF NPs) are crystalline hybrid micro- or mesoporous nanomaterials that show great promise in biomedicine due to their significant drug loading ability and controlled release. Herein, we develop porous capsules from aggregate nanoparticles the iron carboxylate MIL-100(Fe) through a low-temperature spray-drying route. This enables concomitant one-pot encapsulation high an antitumor drug, methotrexate, within pores MOF NPs, collagenase enzyme (COL),...

10.3390/ijms23147670 article EN International Journal of Molecular Sciences 2022-07-12

Abstract The timing and location of senescent cells in vivo is a leading candidate explanation for human aging. A rapidly developing scientific field with the potential to slow aging process creation pharmacologically active medicines that target cells. Senotherapeutics have been developed selectively or preferentially eliminate Senolytic compounds delay animal models are being explored humans great hope. Nanoparticle (NP) drug delivery strategies targeting their infancy, but advancements...

10.1515/ntrev-2023-0211 article EN cc-by Nanotechnology Reviews 2024-01-01

Understanding the interplay between nanoparticles (NPs) and cells is essential to designing more efficient nanomedicines. Previous research has shown role of cell cycle having impact on efficiency cellular uptake accumulation NPs. However, there a limited investigation into biological fate NPs in that are permanently withdrawn from cycle. Here we utilize senescent WI-38 fibroblasts, which do not divide provide definitive model for tracking silica (SiNPs) independent We use several methods...

10.1038/s41598-022-26979-1 article EN cc-by Scientific Reports 2023-01-10

Screening on a relevant 3D tumor model enabled to discard unpromising nanocarriers and may help their opportune optimization successfully reach the target.

10.1039/d1bm00669j article EN Biomaterials Science 2021-01-01

Abstract Despite high morbidity and mortality associated with lung diseases, addressing drugs towards tissue remains a pending task. Particle filtration has been proposed for passive targeting drug delivery. However, toxicity issues derived from the long‐term presence of particles must be overcome. By exploiting some ignored properties nanosized metal–organic frameworks it is possible to achieve impressive antitumoral effects on experimental tumors, even without need engineer surface...

10.1002/anie.201707346 article EN Angewandte Chemie International Edition 2017-09-28
Coming Soon ...